tiprankstipranks
Phibro Animal Health Corp (DE:PB8)
NASDAQ:PB8
Germany Market

Phibro Animal Health (PB8) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

PB8 Analyst Ratings

Moderate Sell
2Ratings
Moderate Sell
0 Buy
1 Hold
1 Sell
Based on 2 analysts giving stock ratings to
Phibro
Animal Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PB8 Stock 12 Month Forecast

Average Price Target

€35.58
▼(-21.28% Downside)
Based on 2 Wall Street analysts offering 12 month price targets for Phibro Animal Health in the last 3 months. The average price target is €35.58 with a high forecast of €38.18 and a low forecast of €32.98. The average price target represents a -21.28% change from the last price of €45.20.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"19":"€19","48":"€48","26.25":"€26.3","33.5":"€33.5","40.75":"€40.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":38.1833738,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€38.18</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35.57996195,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€35.58</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32.9765501,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€32.98</span>\n  </div></div>","useHTML":true}}],"tickPositions":[19,26.25,33.5,40.75,48],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.093,27.023028753846155,27.953057507692307,28.883086261538462,29.813115015384614,30.74314376923077,31.67317252307692,32.60320127692307,33.53323003076923,34.463258784615384,35.393287538461536,36.323316292307695,37.25334504615385,{"y":38.1833738,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.093,26.822766303846155,27.552532607692306,28.28229891153846,29.012065215384617,29.741831519230768,30.471597823076923,31.201364126923075,31.93113043076923,32.660896734615385,33.39066303846154,34.12042934230769,34.85019564615384,{"y":35.57996195,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.093,26.622503853846155,27.152007707692306,27.68151156153846,28.211015415384615,28.740519269230766,29.27002312307692,29.799526976923076,30.329030830769227,30.858534684615382,31.388038538461537,31.917542392307688,32.447046246153846,{"y":32.9765501,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":20.836,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":21.137,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":22.519,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.816,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.495,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":36.071,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.376,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.401,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":33.388,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":45.71,"date":1772323200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":47.207,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":44.418,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":26.093,"date":1780272000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€38.18Average Price Target€35.58Lowest Price Target€32.98
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on DE:PB8
Bank of America Securities
Bank of America Securities
€23.43€32.98
Sell
-27.04%
Downside
Reiterated
06/05/26
Analysts Offer Insights on Healthcare Companies: Phibro Animal Health (NASDAQ: PAHC) and Abivax SA Sponsored ADR (NASDAQ: ABVX)
Citi
€53.8€38.18
Hold
-15.52%
Downside
Assigned
05/14/26
Phibro Animal Health price target lowered to $44 from $62 at CitiPhibro Animal Health price target lowered to $44 from $62 at Citi
J.P. Morgan
€50.33
Buy
11.36%
Upside
Reiterated
02/09/26
Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (NYSE: MTD), Phibro Animal Health (NASDAQ: PAHC) and Siemens Healthineers AG (Other OTC: SEMHF)
Morgan Stanley Analyst forecast on DE:PB8
Morgan Stanley
Morgan Stanley
€39.05€42.52
Hold
-5.92%
Downside
Reiterated
02/06/26
Phibro Animal Health (PAHC) Receives a Hold from Morgan Stanley
Exane BNP Paribas Analyst forecast on DE:PB8
Exane BNP Paribas
Exane BNP Paribas
€20.83€32.11
Hold
-28.96%
Downside
Reiterated
09/04/25
Phibro price target raised to $37 from $24 at BNP Paribas ExanePhibro price target raised to $37 from $24 at BNP Paribas Exane
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on DE:PB8
Bank of America Securities
Bank of America Securities
€23.43€32.98
Sell
-27.04%
Downside
Reiterated
06/05/26
Analysts Offer Insights on Healthcare Companies: Phibro Animal Health (NASDAQ: PAHC) and Abivax SA Sponsored ADR (NASDAQ: ABVX)
Citi
€53.8€38.18
Hold
-15.52%
Downside
Assigned
05/14/26
Phibro Animal Health price target lowered to $44 from $62 at CitiPhibro Animal Health price target lowered to $44 from $62 at Citi
J.P. Morgan
€50.33
Buy
11.36%
Upside
Reiterated
02/09/26
Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (NYSE: MTD), Phibro Animal Health (NASDAQ: PAHC) and Siemens Healthineers AG (Other OTC: SEMHF)
Morgan Stanley Analyst forecast on DE:PB8
Morgan Stanley
Morgan Stanley
€39.05€42.52
Hold
-5.92%
Downside
Reiterated
02/06/26
Phibro Animal Health (PAHC) Receives a Hold from Morgan Stanley
Exane BNP Paribas Analyst forecast on DE:PB8
Exane BNP Paribas
Exane BNP Paribas
€20.83€32.11
Hold
-28.96%
Downside
Reiterated
09/04/25
Phibro price target raised to $37 from $24 at BNP Paribas ExanePhibro price target raised to $37 from $24 at BNP Paribas Exane
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Phibro Animal Health

3 Months
Michael RyskinBank of America Securities
Success Rate
3/12 ratings generated profit
25%
Average Return
-19.53%
Copying Michael Ryskin's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -19.53% per trade.
1 Year
Michael RyskinBank of America Securities
Success Rate
3/12 ratings generated profit
25%
Average Return
-68.28%
Copying Michael Ryskin's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -68.28% per trade.
2 Years
Michael RyskinBank of America Securities
Success Rate
3/12 ratings generated profit
25%
Average Return
-100.84%
Copying Michael Ryskin's trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -100.84% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PB8 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
1
1
1
0
0
Hold
1
1
2
2
2
Sell
2
2
1
0
1
Strong Sell
0
0
0
0
0
total
4
4
4
2
3
In the current month, PB8 has received 0 Buy Ratings, 2 Hold Ratings, and 1 Sell Ratings. PB8 average Analyst price target in the past 3 months is 35.58.
Each month's total comprises the sum of three months' worth of ratings.

PB8 Financial Forecast

PB8 Earnings Forecast

Next quarter’s earnings estimate for PB8 is €0.61 with a range of €0.57 to €0.64. The previous quarter’s EPS was €0.65. PB8 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year PB8 has Performed in-line its overall industry.
Next quarter’s earnings estimate for PB8 is €0.61 with a range of €0.57 to €0.64. The previous quarter’s EPS was €0.65. PB8 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year PB8 has Performed in-line its overall industry.

PB8 Sales Forecast

Next quarter’s sales forecast for PB8 is €327.34M with a range of €324.61M to €334.66M. The previous quarter’s sales results were €329.37M. PB8 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year PB8 has Performed in-line its overall industry.
Next quarter’s sales forecast for PB8 is €327.34M with a range of €324.61M to €334.66M. The previous quarter’s sales results were €329.37M. PB8 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year PB8 has Performed in-line its overall industry.

PB8 Stock Forecast FAQ

What is DE:PB8’s average 12-month price target, according to analysts?
Based on analyst ratings, Phibro Animal Health Corp’s 12-month average price target is 35.58.
    What is DE:PB8’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for DE:PB8, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Phibro Animal Health Corp a Buy, Sell or Hold?
        Phibro Animal Health Corp has a consensus rating of Moderate Sell, which is based on 0 buy ratings, 1 hold ratings and 1 sell ratings.
          What is Phibro Animal Health Corp’s share price target?
          The average share price target for Phibro Animal Health Corp is 35.58. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is €38.18 ,and the lowest forecast is €32.98. The average share price target represents -21.28% Decrease from the current price of €45.2.
            What do analysts say about Phibro Animal Health Corp?
            Phibro Animal Health Corp’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 2 Wall Streets Analysts.
              How can I buy shares of Phibro Animal Health Corp?
              To buy shares of DE:PB8, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.